Donepezil and Sumatriptan succinate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Donepezil (donepezil hydrochloride) and Sumatriptan succinate (sumatriptan succinate). Common drug interactions include depression among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Donepezil and Sumatriptan succinate. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Donepezil?
Donepezil has active ingredients of donepezil hydrochloride. It is often used in dementia. eHealthMe is studying from 24,564 Donepezil users. Check the latest studies of Donepezil.
What is Sumatriptan succinate?
Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.
46 people who take Donepezil and Sumatriptan succinate together, and have interactions are studied.

What are the common drug interactions of Donepezil and Sumatriptan Succinate, by gender? *:
female:
- Depression
- Renal failure (kidney dysfunction)
- Anxiety
- Chronic kidney disease
- Renal disorder (kidney disease)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Nausea (feeling of having an urge to vomit)
- Malaise (a feeling of general discomfort or uneasiness)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Discomfort
male:
- Renal failure (kidney dysfunction)
- Nonspecific reaction (unspecified reaction)
- Renal impairment (severely reduced kidney function)
- Renal tubular necrosis (death of kidney tubules)
- Haemorrhage (bleeding)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Emotional distress
- Kidney infection
What are the common drug interactions of Donepezil and Sumatriptan Succinate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)
40-49:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Anxiety
- Depression
- Renal disorder (kidney disease)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Renal impairment (severely reduced kidney function)
- Renal tubular necrosis (death of kidney tubules)
- Nephropathy (damage to or disease of a kidney)
50-59:
- Anxiety
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Dyspepsia (indigestion)
- Emotional distress
- Nausea (feeling of having an urge to vomit)
- Osteonecrosis (death of bone)
- Pain
- Depression
60+:
- Fatigue (feeling of tiredness)
- Nonspecific reaction (unspecified reaction)
- Asthenia (weakness)
- Bedridden
- Chronic kidney disease
- Depression
- Fall
- General physical health deterioration (weak health status)
- Hypertensive nephropathy (hypertensive renal disease)
- Malaise (a feeling of general discomfort or uneasiness)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 26.09%
- Parkinson's Disease: 11 people, 23.91%
- Muscle Spasms (muscle contraction): 8 people, 17.39%
- Pain: 6 people, 13.04%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 13.04%
- Immunodeficiency Common Variable: 6 people, 13.04%
- Stress And Anxiety: 4 people, 8.70%
- Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 8.70%
- Blood Pressure Abnormal: 4 people, 8.70%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 6.52%
* Approximation only. Some reports may have incomplete information.
Do you take Donepezil and Sumatriptan succinate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Donepezil (24,564 reports)
- Sumatriptan succinate (9,731 reports)
Browse all drug interactions of Donepezil and Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Donepezil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Donepezil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sumatriptan succinate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on donepezil hydrochloride and sumatriptan succinate (the active ingredients of Donepezil and Sumatriptan succinate, respectively), and Donepezil and Sumatriptan succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mirapex cause Oedema Peripheral? - now
- Could Meropenem cause Respiratory? - a second ago
- Could Fioricet cause Fever? - 3 seconds ago
- Could Omnaris cause Forced Expiratory Volume Decreased? - 5 seconds ago
- Could Neosporin cause Stools - Watery? - 5 seconds ago
- Could Neosporin cause Diarrhea? - 6 seconds ago
- Could Maxalt cause Injection Site Swelling? - 13 seconds ago
- Drug interactions of Protonix and Calquence - 16 seconds ago
- Could Maxalt cause Blood Glucose Increased? - 18 seconds ago
- Could Mevacor cause Pulmonary Embolism? - 22 seconds ago